Why I think rare disease companies are more patient-centric   All pharmaceutical/biotech companies are of course, in essence, patient-centric. However, I feel that companies specialising in rare diseases are often more patient-centric. It’s important to mention what I mean by patient-centric – that is – directing the company’s resources mainly to the activities which patients…